Alps Advisors Inc United Therapeutics Corp Transaction History

Alps Advisors Inc

  • $14.8 Billion
  • Q3 2024

A detailed history of Alps Advisors Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, Alps Advisors Inc holds 1,016 shares of UTHR stock, worth $378,856. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,016
Previous 1,380 26.38%
Holding current value
$378,856
Previous $439,000 17.08%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024
SELL
$311.04 - $363.55 $113,218 - $132,332
-364 Reduced 26.38%
1,016 $364,000
Q2 2024

Aug 13, 2024
SELL
$228.26 - $319.04 $3,880 - $5,423
-17 Reduced 1.22%
1,380 $439,000
Q1 2024

May 14, 2024
SELL
$210.76 - $249.51 $10,116 - $11,976
-48 Reduced 3.32%
1,397 $320,000
Q4 2023

Feb 14, 2024
SELL
$214.88 - $256.94 $10,744 - $12,847
-50 Reduced 3.34%
1,445 $317,000
Q3 2023

Nov 14, 2023
BUY
$211.82 - $248.24 $22,241 - $26,065
105 Added 7.55%
1,495 $337,000
Q2 2023

Aug 14, 2023
BUY
$205.19 - $232.99 $2,051 - $2,329
10 Added 0.72%
1,390 $306,000
Q1 2023

May 10, 2023
BUY
$212.99 - $276.17 $293,926 - $381,114
1,380 New
1,380 $309,000
Q3 2021

Nov 15, 2021
SELL
$179.86 - $214.88 $366,015 - $437,280
-2,035 Closed
0 $0
Q1 2021

May 07, 2021
BUY
$153.94 - $174.85 $313,267 - $355,819
2,035 New
2,035 $340,000
Q4 2020

Feb 03, 2021
SELL
$101.87 - $151.79 $5.77 Million - $8.6 Million
-56,636 Closed
0 $0
Q3 2020

Nov 04, 2020
SELL
$99.9 - $121.13 $339,660 - $411,842
-3,400 Reduced 5.66%
56,636 $5.72 Million
Q2 2020

Aug 05, 2020
SELL
$92.74 - $125.82 $1.65 Million - $2.24 Million
-17,775 Reduced 22.84%
60,036 $7.26 Million
Q1 2020

May 06, 2020
SELL
$79.39 - $115.35 $839,072 - $1.22 Million
-10,569 Reduced 11.96%
77,811 $7.38 Million
Q4 2019

Feb 07, 2020
BUY
$78.31 - $95.34 $77,370 - $94,195
988 Added 1.13%
88,380 $7.79 Million
Q3 2019

Nov 04, 2019
SELL
$74.85 - $85.99 $300,148 - $344,819
-4,010 Reduced 4.39%
87,392 $6.97 Million
Q2 2019

Aug 07, 2019
BUY
$76.06 - $120.81 $1.15 Million - $1.82 Million
15,103 Added 19.79%
91,402 $7.14 Million
Q1 2019

May 01, 2019
SELL
$107.15 - $126.84 $83,791 - $99,188
-782 Reduced 1.01%
76,299 $8.96 Million
Q4 2018

Feb 04, 2019
SELL
$101.4 - $128.73 $387,550 - $492,006
-3,822 Reduced 4.72%
77,081 $8.39 Million
Q3 2018

Oct 25, 2018
BUY
$113.81 - $129.46 $2.05 Million - $2.33 Million
18,015 Added 28.65%
80,903 $10.3 Million
Q2 2018

Aug 02, 2018
BUY
$101.14 - $118.31 $6.36 Million - $7.44 Million
62,888 New
62,888 $7.12 Million

Others Institutions Holding UTHR

# of Institutions
669
Shares Held
42.8M
Call Options Held
194K
Put Options Held
295K
View Full List

About UNITED THERAPEUTICS Corp

UTHR Quotes by TradingView
  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $17B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email